Finance

Lists
AHCO:NASDAQ
Adapthealth Corp
6,34 $
+1,44%
(+0,090) 1D
15 қаз., 10:17:33 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHCO...
Open
6,25 $
High
6,35 $
Low
6,17 $
Mkt. cap
864,42 млн
Avg. vol.
2,60 млн
Volume
82,50 мың
52-wk high
13,43 $
52-wk low
5,21 $
EPS
-1,68 $
Beta
1,42
Shares outstanding
136,34 млн
No. of employees
11 мың
Open
6,25 $
High
6,35 $
Low
6,17 $
Mkt. cap
864,42 млн
Avg. vol.
2,60 млн
Volume
82,50 мың
52-wk high
13,43 $
52-wk low
5,21 $
EPS
-1,68 $
Beta
1,42
Shares outstanding
136,34 млн
No. of employees
11 мың
News stories
From web sources and news partners
About Adapthealth Corp
CEO-
Employees10,9 мың
Founded2012
HeadquartersConshohocken, Пенсильвания, Америка Құрама Штаттары
SectorHealth care provider
Analyst ratings
Based on 6 analysts giving stock ratings to AHCO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AHCO in the last 3 months.
Highest
Current 6,34 $
10,00 $ (+57,73%)
Average
9,40 $ (+48,26%)
Lowest
8,00 $ (+26,18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Coldwell
Robert W. Baird
Buy
Maintained
9,00 $
+42%
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
10,00 $
+57,7%
09/15/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/09/2026
Richard Close
Canaccord Genuity
Buy
Maintained
10,00 $
+57,7%
09/09/2026
Kevin Caliendo
UBS
Buy
Reiterated
10,00 $
+57,7%
08/24/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
8,00 $
+26,2%
08/05/2026
Jack Slevin
Jefferies
Buy
Upgraded
13,00 $
+105%
07/21/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
9,50 $
+49,8%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
820,31 млн
846,29 млн
679,87 млн
740,31 млн
Cost of goods sold
639,98 млн
661,38 млн
563,34 млн
611,86 млн
Cost of revenue
639,98 млн
661,38 млн
563,34 млн
611,86 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
103,10 млн
122,54 млн
114,78 млн
114,26 млн
Operating expense
113,20 млн
132,47 млн
121,95 млн
122,21 млн
Total operating expenses
753,18 млн
793,85 млн
685,29 млн
734,07 млн
Operating income
67,13 млн
52,44 млн
-5,42 млн
6,24 млн
Other non operating income
-
726,00 м.
-
-
EBT including unusual items
36,35 млн
-97,99 млн
-31,02 млн
-165,33 млн
EBT excluding unusual items
41,75 млн
28,72 млн
-31,02 млн
-19,97 млн
Income tax expense
10,60 млн
3,54 млн
-7,16 млн
-21,23 млн
Effective tax rate
29,16%
-3,62%
23,10%
12,84%
Other operating expenses
-
-
-
-
Net income
24,51 млн
-102,77 млн
-16,04 млн
-133,93 млн
Net profit margin
2,99%
-12,14%
-2,36%
-18,09%
Earnings per share
0,23
0,27
-0,05
-0,07
Interest and investment income
-
-
-
-
Interest expense
-25,38 млн
-24,44 млн
-25,59 млн
-26,21 млн
Net interest expenses
-25,38 млн
-24,44 млн
-25,59 млн
-26,21 млн
Depreciation and amortization charges
10,10 млн
9,93 млн
7,17 млн
7,95 млн
EBITDA
157,75 млн
149,94 млн
106,09 млн
131,57 млн
Gain or loss from assets sale
-
-377,00 м.
-
-6,27 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары